Literature DB >> 11226551

Does psychiatric comorbidity increase the length of stay in general hospitals?

J Wancata1, N Benda, J Windhaber, M Nowotny.   

Abstract

Several studies reported that in non-psychiatric hospital departments mentally ill patients have a longer length of hospital stay than mentally well. But their methods are often limited because other predictors of length of stay were excluded from statistical analyses. Using the Clinical Interview Schedule, research psychiatrists interviewed 993 patients of medical, surgical, gynecological, and rehabilitation departments in Austria. Using several multiple regression analyses, the influence of psychiatric comorbidity and other variables on length of stay was analyzed. 32.2% of all patients suffered from psychiatric morbidity. Of all psychiatric cases, 6.2% received more than one psychiatric diagnosis. Presence of psychiatric disorders, age, a diagnosis of neoplasms, number of all somatic diagnoses, and the number of previous non-psychiatric hospital admissions predicted length of stay. Patients with dementia, with substance abuse disorders, and with alcohol- and drug-related psychiatric disorders showed a significantly increased length of stay, while other psychiatric diagnoses did not differ from the mentally well. Even after controlling for confounding variables, dementia and substance related diagnoses increase the length of hospital stay. It is important to investigate interventions for early recognition and treatment of these disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11226551     DOI: 10.1016/s0163-8343(00)00110-9

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  13 in total

1.  Psychiatric illness and length of stay in general hospitals: do case finding methods matter?

Authors:  Marion Freidl; Norbert Benda; Fabian Friedrich
Journal:  Neuropsychiatr       Date:  2015-04-28

2.  [Psychiatric comorbidities in visceral surgery patients with cancer].

Authors:  O Krauss; J Hauss; S Jonas; S Leinung; U Halm; C Albani; S Singer
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

3.  [Care differences in a consultation and liaison service].

Authors:  J Valdés-Stauber; S Bachthaler
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

4.  Length of hospitalization and hospital readmissions among patients with substance use disorders in New York City, NY USA.

Authors:  Tawandra L Rowell-Cunsolo; Jianfang Liu; Gloria Hu; Elaine Larson
Journal:  Drug Alcohol Depend       Date:  2020-04-27       Impact factor: 4.492

5.  The criterion validity of different versions of the General Health Questionnaire among non-psychiatric inpatients.

Authors:  Fabian Friedrich; Rainer Alexandrowicz; Norbert Benda; Gero Cerny; Johannes Wancata
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-04-28       Impact factor: 4.328

6.  The impact of psychiatric comorbidity on general hospital length of stay.

Authors:  Sara K Bressi; Steven C Marcus; Phyllis L Solomon
Journal:  Psychiatr Q       Date:  2006

7.  Identifying tumor patients' depression.

Authors:  Susanne Singer; Anna Brown; Jens Einenkel; Johann Hauss; Andreas Hinz; Andrea Klein; Kirsten Papsdorf; Jens-Uwe Stolzenburg; Elmar Brähler
Journal:  Support Care Cancer       Date:  2010-09-19       Impact factor: 3.603

8.  Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?

Authors:  Sharon Reif; Andrea Acevedo; Deborah W Garnick; Catherine A Fullerton
Journal:  Psychiatr Serv       Date:  2017-04-17       Impact factor: 3.084

9.  Burden of Mental Illness among Primary HIV Discharges: A Retrospective Analysis of Inpatient Data.

Authors:  Robert M Avina; Jim E Banta; Ronald Mataya; Benjamin J Becerra; Monideepa B Becerra
Journal:  Healthcare (Basel)       Date:  2022-04-26

10.  Hospital costs associated with psychiatric comorbidities: a retrospective study.

Authors:  Jan Wolff; Thomas Heister; Claus Normann; Klaus Kaier
Journal:  BMC Health Serv Res       Date:  2018-01-30       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.